Session Type
Meeting
Search Results for COP
Abstract Number: 157
Hospital Medicine 2020, Virtual Competition
Background: There is literature to suggest there is a subtype of COPD patients in which eosinophils may play an important role. Data suggests that this subset of patient are more prone to develop exacerbations, but also have a higher likelihood of responding to inhaled corticosteroid therapy. The objective of this study is to determine if […]
Abstract Number: 165
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: The number of hospitals with dedicated observation units has grown in recent years to one-third of all United States hospitals and 80% of academic medical centers, though much is still unknown about how to best deliver care in this setting. At our institution, syncope is among the most common indications for admission to the […]
Abstract Number: 178
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hospital Readmission Reduction Program(HRRP) implemented by CMS as part of Affordable Care Act (ACA) applies financial penalties to hospitals that have higher-than-expected readmission rates for common conditions such as AMI, pneumonia, and HF. CMS extended this program to include COPD for the fiscal year (FY) 2015. While there has been a reduction in readmissions, […]
Abstract Number: 183
Hospital Medicine 2020, Virtual Competition
Background: Syncope is usually an isolated occurrence in younger patients whereas it is multi factorial with many predisposing factors in the elderly. Medication use, co-morbidities and functional decline further complicate syncope evaluation in the elderly. Hence, elderly patients presenting with syncope must be risk stratified uniquely. San Francisco Syncope Rule (SFSR) and Evaluation of Guidelines […]
Abstract Number: 183
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Several studies attest the effectiveness of physician order set, also known as Power Plan (PP) in standardizing patient care and improving outcomes. In general, PP use is suboptimal. We hypothesized that PP use in patients admitted with Chronic Obstructive Pulmonary Disease (COPD) assists in standardization and appropriateness of inpatient management. Methods: We conducted a […]
Abstract Number: 214
SHM Converge 2024
Background: Tobacco cessation is the most effective intervention for reducing the progression of disease in COPD patients and reducing mortality. Varenicline is the most effective drug to treat tobacco use disorder. The American Thoracic Society strongly recommends initiation of Varenicline for smoking cessation, even in patients who are not ready to quit. Hospitalist initiation of […]
Abstract Number: 216
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: COPD exacerbations are among the leading causes of hospital readmissions. According to the COPD Foundation, in 2013, 22% patients admitted for COPD exacerbation required readmission within 30 days of discharge. This represents a significant burden in terms of morbidity for these patients and increased cost to the healthcare system. The COPD readmission rate during […]
Abstract Number: 239
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: The original goal of progress notes is to provide a concise, up-to-date reflection of the patient’s condition and the provider’s thought processes. Electronic health records (EHRs) allow physicians to supplement traditional manual data entry with copied or imported text in these notes. However, this increases the risk of including outdated, inaccurate, or unnecessary information, […]
Abstract Number: 256
SHM Converge 2024
Background: eHealth interventions provide opportunities to enhance asthma or COPD self-management, though eHealth literacy (eHL) needs to be evaluated in this population. We evaluated the association between eHL and self-efficacy, as well as the willingness to use eHealth applications in patients hospitalized for chronic lung diseases (i.e., asthma and COPD). Methods: This cross-sectional observational study […]
Abstract Number: 263
SHM Converge 2024
Background: Inhaled treatments are the cornerstone of management of obstructive lung disease, though patients frequently misuse inhalers, leading to worse disease outcomes. Since the COVID-19 pandemic, there has been increased interest in video-module based interventions for patients with chronic diseases. However, patients’ ability to interact with such educational resources necessitates access to technology and proficiency […]